Results 131 to 140 of about 5,960 (183)

Estimation of Respiratory Syncytial Virus-attributable hospitalizations among older adults in Japan between 2015 and 2018: An administrative health claims database analysis. [PDF]

PLoS One
Seki M, Kobayashi Y, Méroc E, Kitano T, Polkowska-Kramek A, Yoshida A, Ito S, Liang C, Bruyndonckx R, Moges SM, Conde-Sousa E, Nuttens C, Gessner BD, Begier E.   +13 more
europepmc   +1 more source

Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study. [PDF]

Clinicoecon Outcomes Res
Yoshihara S, Meche A, Hlavacek P, Johnson SMA, Demers AS, Nador G, Ikoma S, Yadav CP, Assaf CAL, DiBonaventura M, Chen Y.   +10 more
europepmc   +1 more source

Changes in prescription patterns and drug costs following the launch of generic pemetrexed products: a retrospective study in Japan. [PDF]

J Pharm Health Care Sci
Ichie T, Suzuki D, Yamashita S, Naruse K, Hayashi H.   +4 more
europepmc   +1 more source

Pathology and Molecular Diagnosis of Marek's Disease Virus in Chickens in Nigeria. [PDF]

Scientifica (Cairo)
Fagbohun OA, Oluladun AC, Jarikre TA, Alaka OO, Oyagbemi AA, Adesina RD, Esan OO, Akinniyi OO, Adetona MO, Omobowale TO, Mamoh UJ, Jaja IF.   +11 more
europepmc   +1 more source

The emergence of a highly pathogenic marek's disease virus featuring newly identified mutations in Meq oncogene in Southern China. [PDF]

Virol J
Luo Q, Li H, Ge Z, Chen Z, Chen R.
europepmc   +1 more source

Correction to "From Mitochondria to Immunity: The Emerging Roles of Mitochondria-Derived Vesicles and Small Extracellular Vesicles in Cellular Communication and Disease". [PDF]

J Extracell Vesicles
europepmc   +1 more source